Morning Briefing
Summaries of health policy coverage from major news organizations
Viewpoints: Mifepristone Ruling Makes Drug Development Tricky; Hantavirus Outbreak Shows Risk Of WHO Absence
Stat: Mifepristone Court Ruling Puts Biopharma Industry At Risk
The biotech industry has long operated on a simple premise: FDA-regulated, evidence-based science determines how medicines reach patients, not litigation. That premise was already tested in an earlier Texas case challenging mifepristone’s Food and Drug Administration approval — an unprecedented effort to unwind decades of scientific review through the courts. It is now, once again, under strain. (Grace Colon, 5/4)
Stat: Hantavirus Cruise Ship Outbreak A Warning Sign For World Cup Travel
Three passengers are dead. Seven people are ill. The ship is anchored off Cape Verde, passengers cannot disembark, and the World Health Organization is coordinating the response. (Krutika Kuppalli, 5/5)
The New York Times: Disabled People Are Being Abandoned By The G.O.P.
George H.W. Bush showed how Republicans can be disabled Americans’ greatest allies. Why isn’t Donald Trump honoring his legacy? (Laurence Jurdem, 5/4)
Stat: What Happens When A Doctor Returns To Their Home Country
About 10 years after a breast surgeon we interviewed returned to Dubai to practice, a colleague stopped her in a hospital corridor to tell her: “It’s great — since you came back I no longer see those advanced cases of breast cancer.” (Maia Chankseliani, 5/5)
The New York Times: This Is The Biggest Culprit For High Health Care Spending
Prices at hospitals have grown faster than prices in virtually any other sector of the economy. (Zack Cooper, 5/4)
